Cafepharma Today

February 28 2025 - Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M
U.S. health agencies participated in WHO flu meeting despite planned exit
Teva targets schizophrenia to build on innovative medicines growth
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alpharma agrees to share confidential financials with suitor King Pharmaceuticals
Yahoo/AP
Tuesday, October 7, 2008 - 8:21am
tags:
Medicine for a sector
FT.com
Tuesday, October 7, 2008 - 7:53am
tags:
Medtronic CEO Hawkins Says Stent Patent Win Worth $114 Million
Bloomberg
Tuesday, October 7, 2008 - 7:52am
tags:
UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tuesday, October 7, 2008 - 7:50am
tags:
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tuesday, October 7, 2008 - 7:49am
tags:
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tuesday, October 7, 2008 - 7:46am
tags:
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tuesday, October 7, 2008 - 7:45am
tags:
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tuesday, October 7, 2008 - 7:44am
tags:
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tuesday, October 7, 2008 - 7:43am
tags:
Dendreon Misses, Moves Up
Forbes
Monday, October 6, 2008 - 10:58am
tags:
September FDA news in review
Fierce Pharma
Monday, October 6, 2008 - 10:57am
tags:
Icahn Wins, But Bristol Isn't A Total Loser Either
Forbes
Monday, October 6, 2008 - 10:56am
tags:
Dr. Reddy's Falls After Report on Diabetes Drug Delay
Bloomberg
Monday, October 6, 2008 - 10:27am
tags:
Genentech and OSI say Avastin and Tarceva miss main goal in late-stage clinical trial
Yahoo/AP
Monday, October 6, 2008 - 9:31am
tags:
BioSante Pharma Reaquires Elestrin
Seeking Alpha
Monday, October 6, 2008 - 9:31am
tags:
Discovery Labs: The Next Biotech Buy?
Seeking Alpha
Monday, October 6, 2008 - 9:30am
tags:
[video]Lilly/ImClone Deal
CNBC
Monday, October 6, 2008 - 9:29am
tags:
J&J biologic Crohn's disease drug outperforms standard immune-damping pill in company study
Yahoo/AP
Monday, October 6, 2008 - 9:20am
tags:
Momenta Pharma Investors In Waiting Game on Enoxaparin
Seeking Alpha
Monday, October 6, 2008 - 9:19am
tags:
Bayer's Riociguat Lung Drug Shows Exercise Benefit in Study
Bloomberg
Monday, October 6, 2008 - 9:18am
tags:

Pages

Latest CP Wire Articles

FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Latest Pharmagather Articles

Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
The Thiazide Target, At Last
In the Pipeline
Drug Channels News Roundup, February 2025: Part D vs. Pharmacies, Accumulator Madness, Wholesaler Vertical Integration, IRA vs. MDs, and a 340B Cartoon
Drug Channels
Neurodegeneration Might Come Down to RNA
In the Pipeline
From Data Gaps to Revenue Gains: Harnessing the Power of Comprehensive Data to Drive GTN
Drug Channels
Paxlovid: You'd Have Expected More
In the Pipeline
The Continuing Crisis, Part V: What the NIH Is Telling Its People
In the Pipeline
What the Antifungals Are Really Doing
In the Pipeline

Latest Jobs

Clinical Account Executive
Sanford, Florida, 32771
SOFIE
Sales Representative
Airway Heights, Washington, 99001
Bartlett Roofing
Sales Representative
Spokane, Washington, 99208
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Spokane, Washington, 99204
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative - Paid Training
Greenacres, Washington, 99016
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Spokane, Washington, 99216
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Veradale, Washington, 99037
Bartlett Roofing
Sales Representative - Paid Training
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative
SPOKANE VALLEY, Washington, 99027
Bartlett Roofing
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information